Lorna J. Hale

Lorna J. Hale

Auto-generated profile, based on publicly available information

Lorna J. Hale

Murdoch Childrens Research Institute

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2010 in Cell Metabolism
Verified
Journal Article
Closed access
GWGavin Welsh
Gavin Welsh
LHLorna J. Hale
Lorna J. Hale
VEVera Eremina
Vera Eremina
MJMarie Jeansson
Marie Jeansson
YMYoshiro Maezawa
Yoshiro Maezawa
RCRichard Coward
Richard Coward

20 December 2018 in Nature Methods
Verified
Journal Article
Closed access
PDF file
BPBelinda Phipson
Belinda Phipson
PEPei X. Er
Pei X. Er
ACAlexander N. Combes
Alexander N. Combes
TFThomas Alexander Forbes
Thomas Alexander Forbes
SHSara E. Howden
Sara E. Howden
MLMelissa H. Little
Melissa H. Little

4 December 2018 in Nature Communications
Verified
Journal Article
Open access
PDF file
LHLorna J. Hale
Lorna J. Hale
SHSara E. Howden
Sara E. Howden
BPBelinda Phipson
Belinda Phipson
ALAndrew Lonsdale
Andrew Lonsdale
PEPei X. Er
Pei X. Er
MLMelissa H. Little
Melissa H. Little
The podocytes within the glomeruli of the kidney maintain the filtration barrier by forming interdigitating foot processes with intervening slit diaphragms, disruption in which results in proteinuria. Studies into human podocytopathies to date have employed primary or immortalised podocyte cell lines cultured in 2D. Here we compare 3D human glomeruli sieved from induced pluripotent stem cell-derived kidney organoids with conditionally immortalised human podocyte cell lines, revealing improved podocyte-specific gene expression, maintenance in vitro of polarised protein localisation and an improved glomerular basement membrane matrisome compared to 2D cultures. Organoid-derived glomeruli retain marker expression in culture for 96 h, proving amenable to toxicity screening. In addition, 3D organoid glomeruli from a congenital nephrotic syndrome patient with compound heterozygous NPHS1 mutations reveal reduced protein levels of both NEPHRIN and PODOCIN. Hence, human iPSC-derived organoid glomeruli represent an accessible approach to the in vitro modelling of human podocytopathies and screening for podocyte toxicity.

1 May 2018 in The American Journal of Human Genetics
Verified
Journal Article
Closed access
TFThomas Alexander Forbes
Thomas Alexander Forbes
SHSara E. Howden
Sara E. Howden
KLKynan Lawlor
Kynan Lawlor
BPBelinda Phipson
Belinda Phipson
JMJovana Maksimovic
Jovana Maksimovic
MLMelissa H. Little
Melissa H. Little

1 February 2015 in American Journal of Kidney Diseases
Verified
Journal Article
Closed access
LBLeon Bach
Leon Bach
LHLorna J. Hale
Lorna J. Hale

15 July 2013 in American Journal of Physiology-Renal Physiology
Verified
Journal Article
Closed access
PDF file
LHL. J. Hale
L. J. Hale
JHJ. Hurcombe
J. Hurcombe
ALA. Lay
A. Lay
BSB. Santamaría
B. Santamaría
ÁVÁngela M. Valverde
Ángela M. Valverde
RCRichard Coward
Richard Coward
Podocytes are critically important for maintaining the integrity of the glomerular filtration barrier and preventing albuminuria. Recently, it has become clear that to achieve this, they need to be insulin sensitive and produce an optimal amount of VEGF-A. In other tissues, insulin has been shown to regulate VEGF-A release, but this has not been previously examined in the podocyte. Using in vitro and in vivo approaches, in the present study, we now show that insulin regulates VEGF-A in the podocyte in both mice and humans via the insulin receptor (IR). Insulin directly increased VEGF-A mRNA levels and protein production in conditionally immortalized wild-type human and murine podocytes. Furthermore, when podocytes were rendered insulin resistant in vitro (using stable short hairpin RNA knockdown of the IR) or in vivo (using transgenic podocyte-specific IR knockout mice), podocyte VEGF-A production was impaired. Importantly, in vivo, this occurs before the development of any podocyte damage due to podocyte insulin resistance. Modulation of VEGF-A by insulin in the podocyte may be another important factor in the development of glomerular disease associated with conditions in which insulin signaling to the podocyte is deranged.